Bavarian Nordic A/S (BVNKF)
24.99
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Bavarian Nordic Revenue (Quarterly): 121.11M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 121.11M |
| December 31, 2023 | 353.19M |
| September 30, 2023 | 201.00M |
| June 30, 2023 | 290.35M |
| March 31, 2023 | 180.56M |
| December 31, 2022 | 177.40M |
| September 30, 2022 | 135.87M |
| June 30, 2022 | 76.83M |
| March 31, 2022 | 48.28M |
| December 31, 2021 | 83.67M |
| September 30, 2021 | 71.13M |
| June 30, 2021 | 59.96M |
| March 31, 2021 | 86.77M |
| December 31, 2020 | 36.67M |
| September 30, 2020 | 87.73M |
| June 30, 2020 | 103.31M |
| March 31, 2020 | 53.94M |
| December 31, 2019 | 43.02M |
| September 30, 2019 | 21.47M |
| June 30, 2019 | 15.25M |
| March 31, 2019 | 19.30M |
| December 31, 2018 | 27.71M |
| September 30, 2018 | 34.58M |
| June 30, 2018 | 13.83M |
| March 31, 2018 | 1.863M |
| Date | Value |
|---|---|
| December 31, 2017 | 6.473M |
| September 30, 2017 | 116.04M |
| June 30, 2017 | 58.74M |
| March 31, 2017 | 28.32M |
| December 31, 2016 | 60.22M |
| September 30, 2016 | 67.82M |
| June 30, 2016 | 17.70M |
| March 31, 2016 | 3.335M |
| December 31, 2015 | 46.57M |
| September 30, 2015 | 11.78M |
| June 30, 2015 | 57.62M |
| March 31, 2015 | 35.56M |
| December 31, 2014 | 90.82M |
| September 30, 2014 | 40.05M |
| June 30, 2014 | 30.23M |
| March 31, 2014 | 52.48M |
| December 31, 2013 | 61.59M |
| September 30, 2013 | 56.67M |
| June 30, 2013 | 61.38M |
| March 31, 2013 | 36.40M |
| December 31, 2012 | 46.40M |
| September 30, 2012 | 51.10M |
| June 30, 2012 | 47.93M |
| March 31, 2012 | 29.59M |
| December 31, 2011 | 66.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
15.25M
Minimum
Jun 2019
353.19M
Maximum
Dec 2023
112.38M
Average
85.22M
Median
Revenue (Quarterly) Benchmarks
| Zealand Pharma A/S | 2.198M |
| Genmab A/S | 603.46M |
| Ascendis Pharma A/S | 104.16M |
| Galecto Inc | -- |
| Evaxion Biotech AS | 0.051M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.67M |
| Total Expenses (Quarterly) | 139.88M |
| EPS Diluted (Quarterly) | -0.2185 |
| Enterprise Value | 1.619B |
| Gross Profit Margin (Quarterly) | 31.90% |
| Profit Margin (Quarterly) | -13.76% |
| Earnings Yield | 7.46% |
| Operating Earnings Yield | 7.57% |
| Normalized Earnings Yield | 7.398 |